Joint (JYNT) Competitors $9.80 -0.07 (-0.71%) As of 03:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock JYNT vs. ABL, APPS, ALTI, TINV, CTO, GAMI, IPXX, GMRE, PKST, and UROYShould you be buying Joint stock or one of its competitors? The main competitors of Joint include Abacus Life (ABL), Digital Turbine (APPS), AlTi Global (ALTI), Tiga Acquisition (TINV), CTO Realty Growth (CTO), GAMCO Investors (GAMI), Inflection Point Acquisition Corp. II (IPXX), Global Medical REIT (GMRE), Peakstone Realty Trust (PKST), and Uranium Royalty (UROY). These companies are all part of the "trading" industry. Joint vs. Its Competitors Abacus Life Digital Turbine AlTi Global Tiga Acquisition CTO Realty Growth GAMCO Investors Inflection Point Acquisition Corp. II Global Medical REIT Peakstone Realty Trust Uranium Royalty Joint (NASDAQ:JYNT) and Abacus Life (NASDAQ:ABL) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation. Is JYNT or ABL more profitable? Abacus Life has a net margin of -0.72% compared to Joint's net margin of -7.02%. Abacus Life's return on equity of 17.65% beat Joint's return on equity.Company Net Margins Return on Equity Return on Assets Joint-7.02% 0.60% 0.16% Abacus Life -0.72%17.65%8.82% Do analysts rate JYNT or ABL? Joint presently has a consensus price target of $16.33, indicating a potential upside of 66.67%. Abacus Life has a consensus price target of $13.13, indicating a potential upside of 120.22%. Given Abacus Life's stronger consensus rating and higher probable upside, analysts plainly believe Abacus Life is more favorable than Joint.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Joint 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Abacus Life 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Does the media favor JYNT or ABL? In the previous week, Joint and Joint both had 2 articles in the media. Joint's average media sentiment score of 1.41 beat Abacus Life's score of 0.72 indicating that Joint is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Joint 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abacus Life 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in JYNT or ABL? 76.9% of Joint shares are owned by institutional investors. 27.9% of Joint shares are owned by company insiders. Comparatively, 47.0% of Abacus Life shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, JYNT or ABL? Joint has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, Abacus Life has a beta of 0.02, suggesting that its stock price is 98% less volatile than the S&P 500. Which has stronger earnings & valuation, JYNT or ABL? Joint has higher earnings, but lower revenue than Abacus Life. Abacus Life is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJoint$51.90M2.90-$5.80M-$0.33-29.70Abacus Life$111.92M5.15-$23.96M-$0.06-99.33 SummaryAbacus Life beats Joint on 11 of the 16 factors compared between the two stocks. Get Joint News Delivered to You Automatically Sign up to receive the latest news and ratings for JYNT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JYNT vs. The Competition Export to ExcelMetricJointMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$150.33M$49.84B$5.70B$10.42BDividend YieldN/A2.01%5.78%4.69%P/E Ratio-29.7010.0275.6626.31Price / Sales2.901.05540.19125.23Price / Cash15.108.5625.6730.68Price / Book7.102.3012.856.40Net Income-$5.80M$2.64B$3.29B$276.69M7 Day Performance-5.41%0.40%1.13%-0.19%1 Month Performance-8.75%-5.93%4.57%6.81%1 Year Performance-15.44%-37.08%68.00%27.76% Joint Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JYNTJoint3.8619 of 5 stars$9.80-0.7%$16.33+66.7%-14.8%$150.33M$51.90M-29.70320Positive NewsABLAbacus Life2.8687 of 5 stars$6.12-1.8%$13.13+114.5%-42.8%$602.84M$111.92M-102.0082APPSDigital Turbine1.9516 of 5 stars$5.46-1.1%$5.17-5.4%+72.0%$598.23M$490.51M-7.09840ALTIAlTi Global1.2568 of 5 stars$3.81-1.8%N/A-3.2%$569.02M$206.93M-2.12490TINVTiga AcquisitionN/A$15.99+0.8%N/A+30.5%$551.66MN/A0.00N/AHigh Trading VolumeCTOCTO Realty Growth3.7754 of 5 stars$16.12-1.3%$22.00+36.5%-16.1%$537.90M$124.52M-14.0230Buyback AnnouncementGAMIGAMCO Investors1.3502 of 5 stars$22.91-0.8%N/A-12.5%$513.46M$231.40M8.68170IPXXInflection Point Acquisition Corp. IIN/A$16.25-0.9%N/A+60.9%$507.81MN/A0.00N/AHigh Trading VolumeGMREGlobal Medical REIT4.7932 of 5 stars$38.06+1.1%$49.58+30.3%-32.2%$503.60M$138.78M543.6930PKSTPeakstone Realty Trust2.0542 of 5 stars$13.73+0.4%$17.50+27.5%-6.3%$503.30M$228.07M-1.5435Positive NewsUROYUranium Royalty0.9177 of 5 stars$4.57+23.2%$4.00-12.5%+73.7%$495.80M$11.19M-457.0010Positive NewsAnalyst RevisionGap UpHigh Trading Volume Related Companies and Tools Related Companies Abacus Life Competitors Digital Turbine Competitors AlTi Global Competitors Tiga Acquisition Competitors CTO Realty Growth Competitors GAMCO Investors Competitors Inflection Point Acquisition Corp. II Competitors Global Medical REIT Competitors Peakstone Realty Trust Competitors Uranium Royalty Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JYNT) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Joint With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JYNT Stock Alerts